Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.06 EUR
−81.73 M EUR
0.00 EUR
62.28 M
About Terns Pharmaceuticals, Inc.
Sector
Industry
CEO
Amy L. Burroughs
Website
Headquarters
Foster City
Founded
2017
FIGI
BBG00ZSLM2M2
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 430 is 5.70 EUR — it has increased by 1.79% in the past 24 hours. Watch TERNS PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange TERNS PHARMACEUTICALS INC stocks are traded under the ticker 430.
430 stock has fallen by −13.64% compared to the previous week, the month change is a 4.59% rise, over the last year TERNS PHARMACEUTICALS INC has showed a −4.20% decrease.
We've gathered analysts' opinions on TERNS PHARMACEUTICALS INC future price: according to them, 430 price has a max estimate of 32.40 EUR and a min estimate of 7.15 EUR. Watch 430 chart and read a more detailed TERNS PHARMACEUTICALS INC stock forecast: see what analysts think of TERNS PHARMACEUTICALS INC and suggest that you do with its stocks.
430 stock is 2.70% volatile and has beta coefficient of 2.45. Track TERNS PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is TERNS PHARMACEUTICALS INC there?
Today TERNS PHARMACEUTICALS INC has the market capitalization of 473.65 M, it has decreased by −15.36% over the last week.
Yes, you can track TERNS PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
TERNS PHARMACEUTICALS INC is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
430 earnings for the last quarter are −0.25 EUR per share, whereas the estimation was −0.29 EUR resulting in a 12.62% surprise. The estimated earnings for the next quarter are −0.29 EUR per share. See more details about TERNS PHARMACEUTICALS INC earnings.
TERNS PHARMACEUTICALS INC revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
430 net income for the last quarter is −19.71 M EUR, while the quarter before that showed −21.23 M EUR of net income which accounts for 7.15% change. Track more TERNS PHARMACEUTICALS INC financial stats to get the full picture.
No, 430 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 66.00 employees. See our rating of the largest employees — is TERNS PHARMACEUTICALS INC on this list?
Like other stocks, 430 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TERNS PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TERNS PHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TERNS PHARMACEUTICALS INC stock shows the strong sell signal. See more of TERNS PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.